Unaudited Condensed Statements Of Cash Flows - USD ($)	5 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2022
Cash Flows from Operating Activities:
Net income (loss)	$ (4,754,704)	$ 2,490,844
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Interest income earned on Trust Account	(4,574)	(1,220,785)
Loss upon issuance of Private Placement Warrants	4,256,000	0
Offering costs associated with derivative warrant liabilities	40,524	0
Change in fair value of derivative warrant liabilities	336,000	(2,352,000)
Changes in operating assets and liabilities:
Prepaid expenses	(1,039,267)	371,758
Franchise tax payable	88,817	(77,485)
Accounts payable	1,014,750	39,750
Income tax payable		256,369
Due to related parties	0	15,003
Accrued expenses	(6,181)	(21,800)
Net cash used in operating activities	(68,635)	(498,346)
Cash Flows from Investing Activities
Withdrawal from trust for payment of franchise tax	0	225,965
Principal deposited in Trust Account	(234,600,000)	0
Net cash provided by (used in) investing activities	(234,600,000)	225,965
Cash Flows from Financing Activities:
Proceeds from issuance of Class B common stock to Sponsor	25,000	0
Proceeds from note payable to related party	300,000	0
Repayment of note payable to related party	(300,000)	0
Proceeds received from Initial Public Offering, gross	230,000,000	0
Proceeds received from Private Placement	11,200,000	0
Offering costs paid	(5,095,674)	0
Net cash provided by financing activities	236,129,326	0
Net change in cash	1,460,691	(272,381)
Cash - beginning of the period	0	342,152
Cash - end of the period	1,460,691	69,771
Supplemental disclosure of noncash activities:
Offering costs included in accounts payable	15,000	0
Offering costs included in accrued expenses	132,563	0
Deferred underwriting commissions in connection with the Initial Public Offering	$ 8,050,000	$ 8,050,000